Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) and Maravai LifeSciences (NASDAQ:MRVI – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends. Profitability This table compares Aclaris Therapeutics and Maravai […]
Maravai LifeSciences Holdings, Inc. Expected to Earn Q3 2023 Earnings of ($0.02) Per Share (NASDAQ:MRVI) modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Rating) – Research analysts at Jefferies Financial Group upped their Q4 2023 EPS estimates for Maravai LifeSciences in a research report issued on Thursday, February 23rd. Jefferies Financial Group analyst B. Couillard now forecasts that the company will post earnings per share of $0.12 for the quarter, up […]